Sector: MedicalNovartis AG (NYSE: NVS)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 264 |
Technical : | 156 |
Performance : | 134 |
Overall: | 217 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 266 |
Technical : | 98 |
Performance : | 129 |
Overall: | 186 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 264 |
Technical : | 73 |
Performance : | 185 |
Overall: | 206 |
Number of Stocks: | 306 |
Headlines
- Let's talk science!
Nov 19, 2009 01:38 PM | NVS
- Dispensary of Hope Partners with Leading Pharma Companies to Expand Prescription Medications Access to Tennesseans in Need
Nov 18, 2009 05:09 PM | AZN, MRK, NVS
- ABLYNX ACHIEVES THIRD MILESTONE IN DRUG DISCOVERY AND DEVELOPMENT COLLABORATION
Nov 18, 2009 12:17 PM | NVS
- ABLYNX ACHIEVES THIRD MILESTONE IN DRUG DISCOVERY AND DEVELOPMENT
COLLABORATION
Nov 18, 2009 12:02 PM | NVS
- /C O R R E C T I O N from Source -- Education for Health/
Nov 18, 2009 08:23 AM | NVS
- Mainstay of the Global Workforce - 40-65 Year Olds - Hit Hardest by Chronic Obstructive Pulmonary Disease (COPD)
Nov 18, 2009 01:31 AM | NVS
- Kyodo news summary-8-
Nov 17, 2009 05:03 PM | MS, MTU, NVS
- Swine flu vaccine works at half-doses: Swiss maker
Nov 17, 2009 01:34 PM | GSK, NVS
- Novartis Influenza A(H1N1) 2009 vaccine US interim data show lower
doses of antigen may suffice to generate a protective immune response
against A(H1N1)
Nov 17, 2009 01:17 AM | NVS
- 10 Conviction Buy Ideas From Our Top Managers
Nov 16, 2009 01:28 PM | AMAT, APOL, BDX, CMCSK, ESI, GENZ
- New Brunswick government reimburses Lucentis(x) for residents suffering from leading cause of age-related vision loss
Nov 16, 2009 01:51 PM | NVS
- QLT Announces Third Quarter Results for 2009
Oct 27, 2009 07:53 AM | NVS, QLTI
- UPI NewsTrack TopNews
Oct 24, 2009 01:17 PM | NVS
- UPI NewsTrack TopNews
Oct 24, 2009 08:34 AM | NVS
- CDC: 16 million flu vaccine doses shipped
Oct 24, 2009 08:12 AM | NVS
- UPI NewsTrack Health and Science News
Sep 15, 2009 05:51 PM | NVS
- FDA approves four H1N1 vaccines
Sep 15, 2009 03:55 PM | NVS
- One-dose H1N1 vaccine may be on the way
Sep 04, 2009 12:27 AM | NVS
- Canada studies asthma drug Xolair risks
Aug 13, 2009 12:37 PM | NVS
- Alcon Profit Rises 2.6% in Second Quarter
Jul 23, 2009 02:13 AM | ACL, AZN, NSRGY, NVS
- AspenBio to Present at the Lazard Capital Market 6th Annual Healthcare Conference
Nov 13, 2009 11:55 AM | APPY, LAZ, NVS
- Bernhard Hampl, Ph.D. Elected to Serve As Executive Chairman of the Board of Directors of Fresenius Kabi Pharmaceuticals Holding, Inc.
Nov 03, 2009 12:52 AM | NVS
- RidgewaterEquity.Com Free Fundamental Sector &Amp; Market Research on PCP, NVS, SPR, MUR, PG and OSK
Oct 27, 2009 07:15 AM | MUR, NVS, OSK, PCP, PG, SPR
- Novus Energy Inc. grants performance warrants and options
Sep 04, 2009 01:08 PM | NVS
- Endo Pharmaceuticals to Partner With ProStrakan to Commercialize FORTESTA(TM) in the U.S.
Aug 26, 2009 09:51 AM | NVS
- Endo Pharmaceuticals Announces Cash Tender Offer for Any and All Outstanding Ledgemont PhaRMA(SM) Secured 16% Notes
Aug 26, 2009 07:55 AM | NVS
- Novus Energy Inc. announces third quarter 2009 results
Aug 25, 2009 06:02 PM | NVS
- Peptimmune Completes Phase Ib Study of PI-2301 in Multiple Sclerosis Patients, and Presentation at ECTRIMS 2009
Aug 25, 2009 11:50 AM | NVS
- BioMed Realty Trust Commemorates Five-Year Anniversary As a Public Company ; Ringing NYSE Closing Bell(R) Today; Provides Tenant Update
Aug 06, 2009 06:53 AM | ARNA, AVII, AZN, BMR, CEPH, EPCT
- Standard & Poor's annonce des modifications a l'indice compose S&P/TSX de croissance
Aug 04, 2009 05:42 PM | NVS, REG
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
NVS
|
Compare to S&P
|
| YTD |
6.99 %
|
-11.62 %
|
| 4 Weeks |
4.17 %
|
3.62 %
|
| 12 Weeks |
17.04 %
|
9.83 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 3.37 %
|
|
EPS Growth in Last Year: 0.00 %
|
|
Sales Growth in Last Quarter: 3.20 %
|
|
Sales Growth in Last Quarter: 3.15 %
|
|
